| N-com | H-com | p value | |
---|---|---|---|---|
(n = 21) | (n = 96) | |||
Total number of items in the SLICC classification criteria, mean | ||||
Including complement | 5.3 ± 1.4 | 7.1 ± 1.9 |  < 0.001 | |
Excluding complement |  | 6.1 ± 1.9 | 0.062 | |
Clinical items based on the SLICC classification criteria | ||||
Total number, mean | 2.9 ± 1.1 | 3.5 ± 1.6 | 0.072 | |
Incidence in each item, n (%) | Â | Â | Â | |
 Acute cutaneous lupus | 16 (76.2) | 54 (56.3) | 0.139 | |
 Chronic cutaneous lupus | 1 (4.8) | 3 (3.1) | 0.552 | |
 Oral ulcer | 2 (9.5) | 19 (19.8) | 0.358 | |
 Nonscarring alopecia | 2 (9.5) | 24 (25.0) | 0.155 | |
 Synovitis (2 or more joins) | 15 (71.4) | 51 (53.1) | 0.150 | |
 Serositis | 3 (14.3) | 23 (24.0) | 0.401 | |
 Renal disorder | 1 (4.8) | 39 (40.6) | 0.002 | |
 Neurological disorder | 0 | 12 (12.5) | 0.121 | |
 Hemolytic anemia | 2 (9.5) | 16 (16.7) | 0.523 | |
 Leukopenia (< 4000/mm3) | 14 (66.7) | 74 (77.1) | 0.402 | |
 Thrombocytopenia (< 100,000/mm3) | 4 (19.0) | 25 (26.0) | 0.588 | |
Immunologic items based on the SLICC classification criteria | ||||
Total number, mean | 2.4 ± 0.7 | 3.6 ± 0.8 |  < 0.001 | |
Number excluding complement, mean |  | 2.6 ± 0.8 | 0.477 | |
Incidence in each item, n (%) | Â | Â | Â | |
ANA levels | Â | Â | Â | |
  > 80 titers | 20 (95.2) | 93 (96.9) | 0.552 | |
  > 40 titers | 21 (100) | 95 (99.0) | 0.999 | |
 Anti-dsDNA antibody | 13 (61.9) | 81 (84.4) | 0.031 | |
 Anti-Sm antibody | 8 (38.1) | 33 (34.4) | 0.803 | |
 Antiphospholipid antibody | 9 (42.9) | 39 (40.6) | 0.999 | |
Low complement | Â | Â | Â | |
 Low C3 | – | 93 (96.9) | – | |
 Low C4 | – | 83 (88.3)* | – | |
 Low CH50 | – | 64 (80.0)* | – | |
Direct Coombs’ test |  |  |  | |
(in the absence of hemolytic anemia) | 0 | 0* | – |